Is this just the beginning of what’s to come with CAR T-cell therapy?

There are a number of CAR T-cell therapies targeting various cancer cell targets and trials in solid tumor like pancreatic cancer, lung cancer, sarcoma, melanoma — all sorts of different cancers in addition to leukemia and lymphoma. These are currently clinical trials, but we expect to see these become approved as a standard of care in the coming years.

You may fill in the form below. Our consultant will help you with the CAR-T trials for solid tumors.